Back to Archived News
GeNOsys Announces New Patent Filing
Wednesday, April 16, 2008
Provo, UT -- GeNOsys Inc. (OTCBB: GNYS), a medical research and development company specializing in pharmaceutical, biotechnical and medical gas generating systems, announces the filing of a patent for a single use, disposable nitric oxide generator. The generator requires no external power source and is designed for use in applications where electricity is not available or the individual being treated desires mobility during treatment. The device generates nitric oxide gas utilizing the Company’s proprietary nitric oxide generating tablets.
Clark M. Mower, Chairman of the Board of GeNOsys, said, "This patent has significant application, particularly in third world countries where healthcare workers can, pursuant to FDA approval, take medical treatment to individuals weakened by illness or disease, rather than requiring them to find means to travel to a center for treatment. We feel this will help reduce the spread of some of the highly infectious diseases. The unique design of this single-use generator provides a very cost-effective solution to a number of treatment applications. We will identify those applications where it can be used most effectively upon receipt of FDA approval and then work to broaden its application and use to other areas."
GeNOsys Inc. (generated nitric oxide systems) is a medical research and development company specializing in pharmaceutical, biotechnical and medical gas generating systems. Nitric oxide gas will be one of the medical gases that will be generated along with various combinations of beneficial medical gases suitable for the control of human disease. GeNOsys management believes it can reduce regulatory time through the use of strategic suppliers. Distribution will be accelerated through the use of already existing distribution networks that currently sell related respiratory products. For further information, see the Company’s Website at: www.genosysusa.com.
This press release may contain forward-looking statements including the Company’s beliefs about its business prospects and future results of operations. These statements involve risks and uncertainties. Among the important additional factors that could cause actual results to differ materially from those forward-looking statements are risks associated with the overall economic environment, changes in anticipated earnings of the company and other factors detailed in the company’s filings with the SEC. In addition, the factors underlying Company forecasts are dynamic and subject to change and therefore those forecasts speak only as of the date they are given. The Company does not undertake to update them; however, it may choose from time to time to update them and if it should do so, it will disseminate the updates to the investing public.
Back to Archived News